Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2691)
All Articles published online
|
Feb 7, 2006 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol 2006; 12(5): 828-829 [PMID: 16521207 DOI: 10.3748/wjg.v12.i5.828] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/828.htm |
| Number | Citing Articles |
| 1 |
Tatsuya Yamashita. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32: 15 doi: 10.2165/1163022-S0-000000000-00000
|
| 2 |
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, Ryoko Yamada, Kazuyoshi Ohkawa, Naoki Hiramatsu, Hideki Hagiwara, Masahide Oshita, Yasuharu Imai, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara. Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment. Hepatology Research 2020; 50(10): 1118 doi: 10.1111/hepr.13547
|
| 3 |
Rei Okada, Yuichiro Otsuka, Yoji Kajiwara, Tetsuya Maeda, Jun Ishii, Kazutaka Kimura, Yu Matsumoto, Yuko Ito, Kimihiko Funahashi, Hideaki Shimada. Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma. Oncology Letters 2024; 27(6) doi: 10.3892/ol.2024.14416
|
| 4 |
Samer Tohme, David A. Geller, Jon S. Cardinal, Hui‐Wei Chen, Vignesh Packiam, Srinevas Reddy, Jennifer Steel, James W. Marsh, Allan Tsung. Radiofrequency ablation compared to resection in early‐stage hepatocellular carcinoma. HPB 2013; 15(3): 210 doi: 10.1111/j.1477-2574.2012.00541.x
|
| 5 |
An Tang, Irene Cruite, Donald G. Mitchell, Claude B. Sirlin. Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ. Abdominal Radiology 2018; 43(1): 3 doi: 10.1007/s00261-017-1292-3
|
| 6 |
G Lewison, R Sullivan. The impact of cancer research: how publications influence UK cancer clinical guidelines. British Journal of Cancer 2008; 98(12): 1944 doi: 10.1038/sj.bjc.6604405
|
| 7 |
Norihiro Kokudo, Kiyoshi Hasegawa, Masaaki Akahane, Hiroshi Igaki, Namiki Izumi, Takafumi Ichida, Shinji Uemoto, Shuichi Kaneko, Seiji Kawasaki, Yonson Ku, Masatoshi Kudo, Shoji Kubo, Tadatoshi Takayama, Ryosuke Tateishi, Takashi Fukuda, Osamu Matsui, Yutaka Matsuyama, Takamichi Murakami, Shigeki Arii, Masatoshi Okazaki, Masatoshi Makuuchi. Evidence‐based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH‐HCC Guidelines). Hepatology Research 2015; 45(2) doi: 10.1111/hepr.12464
|
| 8 |
K. NOUSO, Y. KOBAYASHI, S. NAKAMURA, S. KOBAYASHI, J. TOSHIMORI, K. KUWAKI, H. HAGIHARA, H. ONISHI, Y. MIYAKE, F. IKEDA, H. SHIRAHA, A. TAKAKI, Y. IWASAKI, H. KOBASHI, K. YAMAMOTO. Evolution of prognostic factors in hepatocellular carcinoma in Japan. Alimentary Pharmacology & Therapeutics 2010; 31(3): 407 doi: 10.1111/j.1365-2036.2009.04179.x
|
| 9 |
Eriko Goto, Ryota Masuzaki, Ryosuke Tateishi, Yuji Kondo, Jun Imamura, Tadashi Goto, Hitoshi Ikeda, Masaaki Akahane, Shuichiro Shiina, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. Journal of Gastroenterology 2012; 47(4): 477 doi: 10.1007/s00535-011-0512-9
|
| 10 |
Kiyoshi Hasegawa, Norihiro Kokudo, Masatoshi Makuuchi. Hepatocellular Carcinoma. 2009; : 134 doi: 10.3109/9780203092880-12
|
| 11 |
Shogo Tanaka, Yuji Iimuro, Tadamichi Hirano, Seikan Hai, Kazuhiro Suzumura, Jiro Fujimoto. Outcomes of Hepatic Resection for Large Hepatocellular Carcinoma: Special Reference to Postoperative Recurrence. The American Surgeon™ 2015; 81(1): 64 doi: 10.1177/000313481508100132
|
| 12 |
Masatoshi Kudo, Yusuke Kawamura, Kiyoshi Hasegawa, Ryosuke Tateishi, Kazuya Kariyama, Shuichiro Shiina, Hidenori Toyoda, Yasuharu Imai, Atsushi Hiraoka, Masafumi Ikeda, Namiki Izumi, Michihisa Moriguchi, Sadahisa Ogasawara, Yasunori Minami, Kazuomi Ueshima, Takamichi Murakami, Shiro Miyayama, Osamu Nakashima, Hirohisa Yano, Michiie Sakamoto, Etsuro Hatano, Mitsuo Shimada, Norihiro Kokudo, Satoshi Mochida, Tetsuo Takehara. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer 2021; 10(3): 181 doi: 10.1159/000514174
|
| 13 |
Yoshitaka Takuma, Kazuhiro Nouso, Yasuhiro Makino, Tomoyuki Gotoh, Nobuyuki Toshikuni, Youichi Morimoto, Hiroyuki Shimomura, Hiroshi Yamamoto. Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria. Journal of Gastroenterology and Hepatology 2011; 26(9): 1417 doi: 10.1111/j.1440-1746.2011.06775.x
|
| 14 |
Irene Cruite, An Tang, Claude B. Sirlin. Imaging-Based Diagnostic Systems for Hepatocellular Carcinoma. American Journal of Roentgenology 2013; 201(1): 41 doi: 10.2214/AJR.13.10570
|
| 15 |
Masatoshi Makuuchi, Norihiro Kokudo, Shigeki Arii, Shunji Futagawa, Shuichi Kaneko, Seiji Kawasaki, Yutaka Matsuyama, Masatoshi Okazaki, Kiwamu Okita, Masao Omata, Yukihisa Saida, Tadatoshi Takayama, Yoshio Yamaoka. Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatology Research 2008; 38(1): 37 doi: 10.1111/j.1872-034X.2007.00216.x
|
| 16 |
Kiyoshi Hasegawa, Norihiro Kokudo. Surgical treatment of hepatocellular carcinoma. Surgery Today 2009; 39(10): 833 doi: 10.1007/s00595-008-4024-z
|
| 17 |
Arun J. Sanyal, Seung Kew Yoon, Riccardo Lencioni. The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist 2010; 15(S4): 14 doi: 10.1634/theoncologist.2010-S4-14
|
| 18 |
Lei Jiang, Lijun Xie, Ge Li, Hang Xie, Zhao Fang, Xinran Cai, Yanling Chen. Clinical characteristics and surgical treatments of primary hepatic angiosarcoma. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01743-3
|
| 19 |
Atsushi Hiraoka, Kojiro Michitaka, Norio Horiike, Satoshi Hidaka, Takahide Uehara, Soichi Ichikawa, Aki Hasebe, Yasunao Miyamoto, Tomoyuki Ninomiya, Ichiro Sogabe, Yoshihiro Ishimaru, Hideki Kawasaki, Yohei Koizumi, Masashi Hirooka, Yoshimasa Yamashita, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. Journal of Gastroenterology and Hepatology 2010; 25(2): 403 doi: 10.1111/j.1440-1746.2009.06037.x
|
| 20 |
Paolo Magistri, Giuseppe Tarantino, Cristiano Guidetti, Giacomo Assirati, Tiziana Olivieri, Roberto Ballarin, Andrea Coratti, Fabrizio Di Benedetto. Laparoscopic versus robotic surgery for hepatocellular carcinoma: the first 46 consecutive cases. Journal of Surgical Research 2017; 217: 92 doi: 10.1016/j.jss.2017.05.005
|
| 21 |
Kiyoshi Hasegawa, Norihiro Kokudo, Masatoshi Makuuchi, Namiki Izumi, Takafumi Ichida, Masatoshi Kudo, Yonson Ku, Michiie Sakamoto, Osamu Nakashima, Osamu Matsui, Yutaka Matsuyama. Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey. Journal of Hepatology 2013; 58(4): 724 doi: 10.1016/j.jhep.2012.11.009
|
| 22 |
Kenji Ikeda. Recent advances in medical management of hepatocellular carcinoma. Hepatology Research 2019; 49(1): 14 doi: 10.1111/hepr.13259
|
| 23 |
Shun‐ichi Ariizumi, Yoshihito Kotera, Yutaka Takahashi, Satoshi Katagiri, Masakazu Yamamoto. Impact of hepatectomy for huge solitary hepatocellular carcinoma. Journal of Surgical Oncology 2013; 107(4): 408 doi: 10.1002/jso.23226
|
| 24 |
Kiyoshi Hasegawa, Nobuyuki Takemura, Tatsuya Yamashita, Takeyuki Watadani, Masaki Kaibori, Shoji Kubo, Mitsuo Shimada, Hiroaki Nagano, Etsuro Hatano, Hiroshi Aikata, Hiroko Iijima, Kazuomi Ueshima, Kazuyoshi Ohkawa, Takuya Genda, Kaoru Tsuchiya, Takuji Torimura, Masafumi Ikeda, Junji Furuse, Masaaki Akahane, Satoshi Kobayashi, Hideyuki Sakurai, Atsuya Takeda, Takamichi Murakami, Utaroh Motosugi, Yutaka Matsuyama, Masatoshi Kudo, Ryosuke Tateishi. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines). Hepatology Research 2023; 53(5): 383 doi: 10.1111/hepr.13892
|
| 25 |
|
| 26 |
Masatoshi Makuuchi, Keiji Sano. Surgical treatment of HCC: update topics. Updates in Surgery 2011; 63(2): 67 doi: 10.1007/s13304-011-0069-4
|
| 27 |
Riccardo Lencioni, Xiao-Ping Chen, Lucy Dagher, Alan P. Venook. Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?. The Oncologist 2010; 15(S4): 42 doi: 10.1634/theoncologist.2010-S4-42
|
| 28 |
Kazuhiro Nouso, Yoshiyuki Kobayashi, Shinichiro Nakamura, Sayo Kobayashi, Hiroki Takayama, Junichi Toshimori, Kenji Kuwaki, Hiroaki Hagihara, Hideki Onishi, Yasuhiro Miyake, Fusao Ikeda, Hidenori Shiraha, Akinobu Takaki, Yoshiaki Iwasaki, Haruhiko Kobashi, Kazuhide Yamamoto. Prognostic importance of fucosylated alpha‐fetoprotein in hepatocellular carcinoma patients with low alpha‐fetoprotein. Journal of Gastroenterology and Hepatology 2011; 26(7): 1195 doi: 10.1111/j.1440-1746.2011.06720.x
|
| 29 |
Andrew X. Zhu. Sorafenib Use in Hepatocellular Carcinoma in Japan: Early Experience and Impact on Clinical Practice. Clinical Drug Investigation 2012; 32(S2): 1 doi: 10.1007/BF03265491
|
| 30 |
Eileen L. Yoon, Jong Eun Yeon, Hyun Jung Lee, Sang Jun Suh, Sun Jae Lee, Seong Hee Kang, Keunhee Kang, Yang Jae Yoo, Ji Hoon Kim, Hyung Joon Yim, Kwan Soo Byun. Systemic Cytotoxic Chemotherapy of Patients With Advanced Hepatocellular Carcinoma in the Era of Sorafenib Nonavailability. Journal of Clinical Gastroenterology 2014; 48(3): e22 doi: 10.1097/MCG.0b013e3182a54ec8
|
| 31 |
Masaki Kaibori, Kengo Yoshii, Kiyoshi Hasegawa, Asao Ogawa, Shoji Kubo, Ryosuke Tateishi, Namiki Izumi, Masumi Kadoya, Masatoshi Kudo, Takashi Kumada, Michiie Sakamoto, Osamu Nakashima, Yutaka Matsuyama, Tadatoshi Takayama, Norihiro Kokudo. Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort. Annals of Surgery 2019; 270(1): 121 doi: 10.1097/SLA.0000000000002751
|
| 32 |
Pierce Kah‐Hoe Chow. Resection for hepatocellular carcinoma: Is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?. Journal of Gastroenterology and Hepatology 2012; 27(3): 452 doi: 10.1111/j.1440-1746.2011.07034.x
|
| 33 |
Sheng-Long Ye, Jiamei Yang, Ping Bie, Shuijun Zhang, Xiaoping Chen, Fengyong Liu, Luming Liu, Jie Zhou, Kefeng Dou, Chunyi Hao, Guoliang Shao, Qiang Xia, Yajin Chen, Jijin Yang, Xiaxing Deng, Yunpeng Liu, Yunfei Yuan, Zhiren Fu, Keiko Nakajima, Zhengguang Lv. Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4144-9
|
| 34 |
K Nouso, Y M Ito, K Kuwaki, Y Kobayashi, S Nakamura, Y Ohashi, K Yamamoto. Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis. British Journal of Cancer 2008; 98(7): 1161 doi: 10.1038/sj.bjc.6604282
|
| 35 |
Shun‐ichi Ariizumi, Yoshihito Kotera, Satoshi Katagiri, Masakazu Yamamoto. Favorable long‐term surgical outcomes of hepatocellular carcinoma in patients with hepatitis B envelope antibody. Journal of Surgical Oncology 2010; 101(6): 471 doi: 10.1002/jso.21512
|
| 36 |
Hyunchul Rhim, Hyo K. Lim. Radiofrequency Ablation of Hepatocellular Carcinoma: Pros and Cons. Gut and Liver 2010; 4(Suppl.1): S113 doi: 10.5009/gnl.2010.4.S1.S113
|
| 37 |
Wei Wang, Chuanxin Yang, Jie Wang, Wei Chen, Jian Wang. Hepatolithiasis Classification Based on Anatomical Hepatectomy. Journal of Gastrointestinal Surgery 2023; 27(5): 914 doi: 10.1007/s11605-022-05572-x
|
| 38 |
Atsushi Hiraoka, Takashi Kumada, Kazuhiro Nouso, Kunihiko Tsuji, Ei Itobayashi, Masashi Hirooka, Kazuya Kariyama, Toru Ishikawa, Toshifumi Tada, Hidenori Toyoda, Hideki Kawasaki, Yoichi Hiasa, Kojiro Michitaka. Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade. Oncology 2016; 91(3): 153 doi: 10.1159/000447061
|
| 39 |
Xin Huang, Yingmao Chen, Mingzhe Shao, Can Li, Aiqun Zhang, Jiahong Dong, Canhong Xiang. The value of 99mTc-labeled galactosyl human serum albumin single-photon emission computerized tomography/computed tomography on regional liver function assessment and posthepatectomy failure prediction in patients with hilar cholangiocarcinoma. Nuclear Medicine Communications 2020; 41(11): 1128 doi: 10.1097/MNM.0000000000001263
|
| 40 |
Masatoshi Kudo. International comparison of treatment outcomes based on staging systems. Hepatology Research 2007; 37(s2) doi: 10.1111/j.1872-034X.2007.00188.x
|
| 41 |
T. Takayama. Surgical Treatment for Hepatocellular Carcinoma. Japanese Journal of Clinical Oncology 2011; 41(4): 447 doi: 10.1093/jjco/hyr016
|
| 42 |
Atsushi Hiraoka, Masashi Hirooka, Hironori Ochi, Yohei Koizumi, Yuko Shimizu, Akiko Shiraishi, Hiroka Yamago, Tetsuya Tanihira, Hideki Miyata, Tomoyuki Ninomiya, Hideki Kawasaki, Yoshihiro Ishimaru, Ichiro Sogabe, Takeshi Inoue, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji, Kojiro Michitaka. Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: impact of FDG PET/CT. Liver International 2013; 33(7): 1085 doi: 10.1111/liv.12161
|
| 43 |
Kiong-Ming Wong, Ming-Lun Yeh, Shih-Chung Chuang, Liang-Yen Wang, Zu-Yau Lin, Shinn-Cherng Chen, Jung-Fa Tsai, Shen-Nien Wang, Kung-Kai Kuo, Chia-Yen Dai, Ming-Lung Yu, King-The Lee, Wan-Long Chuang. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma. Indian Journal of Gastroenterology 2013; 32(4): 253 doi: 10.1007/s12664-012-0225-x
|
| 44 |
Carlos Rodríguez de Lope, Silvia Tremosini, Alejandro Forner, María Reig, Jordi Bruix. Management of HCC. Journal of Hepatology 2012; 56: S75 doi: 10.1016/S0168-8278(12)60009-9
|
| 45 |
Linda L Wong, Brenda Y Hernandez, Yurii B Shvetsov, Yoichi Kawano, Zhao-You Tang, Jun-Fang Ji. Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries. World Journal of Hepatology 2016; 8(31): 1327-1335 doi: 10.4254/wjh.v8.i31.1327
|
| 46 |
Fumitoshi Hirokawa, Shoji Kubo, Hiroaki Nagano, Takuya Nakai, Masaki Kaibori, Michihiro Hayashi, Shigekazu Takemura, Hiroshi Wada, Yasuyuki Nakata, Kosuke Matsui, Morihiko Ishizaki, Kazuhisa Uchiyama. Do patients with small solitary hepatocellular carcinomas without macroscopically vascular invasion require anatomic resection? Propensity score analysis. Surgery 2015; 157(1): 27 doi: 10.1016/j.surg.2014.06.080
|
| 47 |
|
| 48 |
Rei Okada, Yuichiro Otsuka, Osamu Yokosuka, Naoya Kato, Fumio Imazaki, Isamu Hoshino, Nobuyuki Sugiura, Hideaki Mizumoto, Ryousaku Azemoto, Kazuki Kato, Hideaki Shimada. Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi‑institutional study. Oncology Letters 2022; 24(4) doi: 10.3892/ol.2022.13487
|
| 49 |
Toru Ishikawa. Future perspectives on the treatment of hepatocellular carcinoma with cisplatin. World Journal of Hepatology 2009; 1(1): 8-16 doi: 10.4254/wjh.v1.i1.8
|
| 50 |
Norihiro Kokudo, Masatoshi Makuuchi. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. Journal of Gastroenterology 2009; 44(S19): 119 doi: 10.1007/s00535-008-2244-z
|
| 51 |
Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, Hidenori Toyoda, Toshifumi Tada, Hidetaro Ueki, Miho Kaneto, Toshihiko Aibiki, Tomonari Okudaira, Takamasa Kawakami, Tomoe Kawamura, Hiroka Yamago, Yoshifumi Suga, Yuji Miyamoto, Hideomi Tomida, Nobuaki Azemoto, Kenichiro Mori, Hideki Miyata, Tomoyuki Ninomiya, Hideki Kawasaki. Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2016; 31(5): 1031 doi: 10.1111/jgh.13250
|
| 52 |
Harpreet Kaur Massaon, Sanjeev Kumar, Pranav Kumar Prabhakar. Association between serum ferritin level and risk of type 2 diabetes mellitus. 14TH INTERNATIONAL CONFERENCE ON MATERIALS PROCESSING AND CHARACTERIZATION 2023 2024; 3007: 030158 doi: 10.1063/5.0192436
|
| 53 |
Tatsuya Yamashita. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32(S2): 15 doi: 10.1007/BF03265493
|
| 54 |
Kiyoshi Hasegawa, Taku Aoki, Takeaki Ishizawa, Junichi Kaneko, Yoshihiro Sakamoto, Yasuhiko Sugawara, Norihiro Kokudo. Comparison of the Therapeutic Outcomes Between Surgical Resection and Percutaneous Ablation for Small Hepatocellular Carcinoma. Annals of Surgical Oncology 2014; 21(S3): 348 doi: 10.1245/s10434-014-3585-x
|
| 55 |
Peipei Song, Wei Tang, Norihiro Kokudo. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_4-1
|
| 56 |
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jiejun Wang, Won Young Tak, Hongming Pan, Karin Burock, Jessie Zou, Dimitris Voliotis, Zhongzhen Guan. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. The Lancet Oncology 2009; 10(1): 25 doi: 10.1016/S1470-2045(08)70285-7
|
| 57 |
Peipei Song, Wei Tang, Kiyoshi Hasegawa, Norihiro Kokudo. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan. Drug Discoveries & Therapeutics 2014; 8(2): 64 doi: 10.5582/ddt.8.64
|
| 58 |
Peipei Song, Wei Tang, Norihiro Kokudo. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 901 doi: 10.1007/978-94-007-7675-3_4
|
| 59 |
Atsushi Nanashima, Junichi Masuda, Satoshi Miuma, Yorihisa Sumida, Takashi Nonaka, Kenji Tanaka, Shigekazu Hidaka, Terumitsu Sawai, Takeshi Nagayasu. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World Journal of Gastroenterology 2008; 14(1): 58-63 doi: 10.3748/wjg.14.58
|
| 60 |
P. Grondona, C. Meola, F. Floris, R. Masini, E. Brignole, F. Quidaciolu. Ultrasound-guided liver resection: Early experience in a district general hospital. Journal of Ultrasound 2008; 11(4): 162 doi: 10.1016/j.jus.2008.09.004
|
| 61 |
Peipei Song, Ruoyan G. Tobe, Yoshinori Inagaki, Norihiro Kokudo, Kiyoshi Hasegawa, Yasuhiko Sugawara, Wei Tang. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver International 2012; 32(7): 1053 doi: 10.1111/j.1478-3231.2012.02792.x
|
| 62 |
Rei Okada, Yuichiro Otsuka, Taiga Wakabayashi, Masahiro Shinoda, Takeshi Aoki, Masahiko Murakami, Shunichi Arizumi, Masakazu Yamamoto, Osamu Aramaki, Tadatoshi Takayama, Shigeki Wakiyama, Katsuhiko Yanaga, Katsumi Amikura, Hironori Kaneko, Hideaki Shimada. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study. International Journal of Cancer 2020; 147(9): 2578 doi: 10.1002/ijc.33165
|
| 63 |
Kiyoshi Hasegawa, Masatoshi Makuuchi, Tadatoshi Takayama, Norihiro Kokudo, Shigeki Arii, Masatoshi Okazaki, Kiwamu Okita, Masao Omata, Masatoshi Kudo, Masamichi Kojiro, Yasuni Nakanuma, Kenichi Takayasu, Morito Monden, Yutaka Matsuyama, Iwao Ikai. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: A preliminary report of the Japanese nationwide survey. Journal of Hepatology 2008; 49(4): 589 doi: 10.1016/j.jhep.2008.05.018
|
| 64 |
Takeshi Tomoda, Kazuhiro Nouso, Akiko Sakai, Mamoru Ouchida, Sayo Kobayashi, Koji Miyahara, Hideki Onishi, Shinichiro Nakamura, Kazuhide Yamamoto, Kenji Shimizu. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study. Journal of Gastroenterology and Hepatology 2012; 27(4): 797 doi: 10.1111/j.1440-1746.2011.06948.x
|
| 65 |
Wei Liu, Kun Wang, Quan Bao, Yi Sun, Bao-Cai Xing. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0811-y
|
| 66 |
Norihiro Kokudo, Nobuyuki Takemura, Kiyoshi Hasegawa, Tadatoshi Takayama, Shoji Kubo, Mitsuo Shimada, Hiroaki Nagano, Etsuro Hatano, Namiki Izumi, Shuichi Kaneko, Masatoshi Kudo, Hiroko Iijima, Takuya Genda, Ryosuke Tateishi, Takuji Torimura, Hiroshi Igaki, Satoshi Kobayashi, Hideyuki Sakurai, Takamichi Murakami, Takeyuki Watadani, Yutaka Matsuyama. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update. Hepatology Research 2019; 49(10): 1109 doi: 10.1111/hepr.13411
|
| 67 |
Masato Nakai, Kenichi Morikawa, Shunichi Hosoda, Sonoe Yoshida, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, Ren Yamada, Masatsugu Ohara, Takuya Sho, Goki Suda, Koji Ogawa, Naoya Sakamoto. Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma. World Journal of Hepatology 2022; 14(7): 1480-1494 doi: 10.4254/wjh.v14.i7.1480
|
| 68 |
Keisuke Inui, Yasuhiro Takahashi, Hirokazu Komeichi, Yasumi Katsuta, Shuji Shimizu, Kyouichi Mizuno. Successful Transcatheter Chemoembolization for Acute Jaundice in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: A Case Report. Journal of Nippon Medical School 2009; 76(4): 217 doi: 10.1272/jnms.76.217
|
| 69 |
Fujimasa Tada, Atsushi Hiraoka, Kosuke Nakatani, Kana Matsuoka, Mai Fukumoto, Takuya Matsuda, Emi Yanagihara, Hironobu Saneto, Taisei Murakami, Kei Onishi, Hirofumi Izumoto, Shogo Kitahata, Kozue Kanemitsu-Okada, Tomoe Kawamura, Taira Kuroda, Jun Hanaoka, Jota Watanabe, Hiromi Ohtani, Osamu Yoshida, Masashi Hirooka, Hideki Miyata, Eiji Tsubouchi, Masanori Abe, Bunzo Matsuura, Tomoyuki Ninomiya, Yoichi Hiasa. Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy. Clinical Journal of Gastroenterology 2024; 17(3): 401 doi: 10.1007/s12328-024-01938-7
|
| 70 |
Sebastian Schmidt, Markus Follmann, Nisar Malek, Michael P. Manns, Tim F. Greten. Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2011; 26(12): 1779 doi: 10.1111/j.1440-1746.2011.06891.x
|
| 71 |
Andrew X. Zhu. Sorafenib Use in Hepatocellular Carcinoma in Japan: Early Experience and Impact on Clinical Practice. Clinical Drug Investigation 2012; 32: 1 doi: 10.2165/1163026-S0-000000000-00000
|
| 72 |
Shigeki Arii, Michio Sata, Michiie Sakamoto, Mitsuo Shimada, Takashi Kumada, Shuichiro Shiina, Tatsuya Yamashita, Norihiro Kokudo, Masatoshi Tanaka, Tadatoshi Takayama, Masatoshi Kudo. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatology Research 2010; 40(7): 667 doi: 10.1111/j.1872-034X.2010.00673.x
|
| 73 |
Won Kyoung Yun, Moon Seok Choi, Dongil Choi, Hyun-Chul Rhim, Jae Won Joh, Kyung Hee Kim, Tae Hoon Jang, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo. Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatology International 2011; 5(2): 722 doi: 10.1007/s12072-010-9237-8
|
| 74 |
Kazunari Tanaka, Kunihiko Tsuji, Takeshi Matsui, Jong‐Hon Kang, Yasuo Sakurai, Yoshihisa Kodama, Ryosuke Minami, Kiichi Watanabe, Akio Katanuma. Potential of PALBI‐T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease. JGH Open 2022; 6(1): 36 doi: 10.1002/jgh3.12705
|
| 75 |
Yuri Cho, Bo Hyun Kim, Joong-Won Park. Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison. Clinical and Molecular Hepatology 2023; 29(2): 252 doi: 10.3350/cmh.2023.0099
|
| 76 |
I. Popescu. Hepatocellular carcinoma – new trends. memo - Magazine of European Medical Oncology 2010; 3(3): 113 doi: 10.1007/s12254-010-0220-9
|
| 77 |
Kiyoshi Hasegawa, Norihiro Kokudo. Hepatocellular Carcinoma:. 2011; : 89 doi: 10.1007/978-1-60327-522-4_7
|
| 78 |
Hyunchul Rhim, Hyo K Lim, Dongil Choi. Current status of radiofrequency ablation of hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2010; 2(4): 128-136 doi: 10.4240/wjgs.v2.i4.128
|
| 79 |
Masatoshi Kudo. Review of 4th Single Topic Conference on HCC. Hepatology Research 2007; 37(s2) doi: 10.1111/j.1872-034X.2007.00167.x
|
| 80 |
ATSUSHI HIRAOKA, MISA ICHIRYU, NAYU TAZUYA, HIRONORI OCHI, ATSUSHI TANABE, HIROMASA NAKAHARA, SATOSHI HIDAKA, TAKAHIDE UEHARA, SOICHI ICHIKAWA, AKI HASEBE, YASUNAO MIYAMOTO, TOMOYUKI NINOMIYA, MASASHI HIROOKA, MASANORI ABE, YOICHI HIASA, BUNZO MATSUURA, MORIKAZU ONJI, KOJIRO MICHITAKA. Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonazoid. Oncology Letters 2010; 1(1): 57 doi: 10.3892/ol_00000010
|
| 81 |
Qiang Wang, Changfeng Li, Geng Chen, Kai Feng, Zhiyu Chen, Feng Xia, Ping Cai, Leida Zhang, Ernesto Sparrelid, Torkel B. Brismar, Kuansheng Ma. Unsupervised Machine Learning of MRI Radiomics Features Identifies Two Distinct Subgroups with Different Liver Function Reserve and Risks of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma. Cancers 2023; 15(12): 3197 doi: 10.3390/cancers15123197
|
| 82 |
E.-L. Zhang, F. Yang, Z.-B. Wu, C.-S. Yue, T.-Y. He, K.-Y. Li, Z.-Y. Xiao, M. Xiong, X.-P. Chen, Z.-Y. Huang. Therapeutic efficacy of percutaneous microwave coagulation versus liver resection for single hepatocellular carcinoma ≤3 cm with Child-Pugh A cirrhosis. European Journal of Surgical Oncology (EJSO) 2016; 42(5): 690 doi: 10.1016/j.ejso.2016.02.251
|
| 83 |
Kiyoshi Hasegawa, Norihiro Kokudo, Keiji Sano, Masatoshi Makuuchi. Single HCC between 2 and 5 cm: the grey zone. Journal of Hepato-Biliary-Pancreatic Sciences 2010; 17(4): 430 doi: 10.1007/s00534-009-0245-9
|
| 84 |
Lorenzo Andreana, Graziella Isgrò, Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs. Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World Journal of Hepatology 2009; 1(1): 48-61 doi: 10.4254/wjh.v1.i1.48
|
| 85 |
Yong Xie, Huan Tian, Hua Xiang. Is transcatheter arterial chemoembolization plus sorafenib better than chemoembolization plus placebo in the treatment of hepatocellular carcinoma?. Tumori Journal 2021; 107(4): 292 doi: 10.1177/0300891620945029
|
| 86 |
Kiyoshi Hasegawa, Masatoshi Makuuchi, Norihiro Kokudo, Namiki Izumi, Takafumi Ichida, Masatoshi Kudo, Yonson Ku, Michiie Sakamoto, Osamu Nakashima, Osamu Matsui, Yutaka Matsuyama. Impact of Histologically Confirmed Lymph Node Metastases on Patient Survival After Surgical Resection for Hepatocellular Carcinoma. Annals of Surgery 2014; 259(1): 166 doi: 10.1097/SLA.0b013e31828d4960
|
| 87 |
Hidetsugu Saito, Tetsuya Masuda, Shinichiro Tada, Hirotoshi Ebinuma, Yoshiyuki Yamagishi, KeiSuke Ojiro, Mika Inoue, Toshifumi Hibi. Hepatocellular Carcinoma in Keio Affiliated Hospitals — Diagnosis, Treatment, and Prognosis of this Disease —. The Keio Journal of Medicine 2009; 58(3): 161 doi: 10.2302/kjm.58.161
|
| 88 |
Atsunori Kusakabe, Shunsuke Nojiri, Etsuko Iio, Kentaro Matsuura, Noboru Shinkai, Tomokatsu Miyaki, Takashi Joh. Case-control study of the RFA therapeutic effect of newly developed 4D US and conventional 2D US. Journal of Medical Ultrasonics 2013; 40(1): 39 doi: 10.1007/s10396-012-0388-1
|
| 89 |
B. Li, J. L. Song, Y. Aierken, Y. Chen, J. L. Zheng, J. Y. Yang. Nonanatomic resection is not inferior to anatomic resection for primary intrahepatic cholangiocarcinoma: A propensity score analysis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-35911-5
|
| 90 |
Atsushi Hiraoka, Takashi Kumada, Ei Itobayashi, Kunihiko Tsuji, Toru Ishikawa, Masashi Hirooka, Kazuya Kariyama, Kazuhiro Nouso, Toshifumi Tada, Hidenori Toyoda, Yoichi Hiasa, Kojiro Michitaka. Prognostic Scoring System for radiofrequency ablation: Usefulness of Albumin-bilirubin (ALBI)-grade. Kanzo 2016; 57(7): 312 doi: 10.2957/kanzo.57.312
|
| 91 |
Masatoshi Kudo, Kazuho Imanaka, Nobuyuki Chida, Kohei Nakachi, Won-Young Tak, Tadatoshi Takayama, Jung-Hwan Yoon, Takeshi Hori, Hiromitsu Kumada, Norio Hayashi, Shuichi Kaneko, Hirohito Tsubouchi, Dong Jin Suh, Junji Furuse, Takuji Okusaka, Katsuaki Tanaka, Osamu Matsui, Michihiko Wada, Iku Yamaguchi, Toshio Ohya, Gerold Meinhardt, Kiwamu Okita. Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. European Journal of Cancer 2011; 47(14): 2117 doi: 10.1016/j.ejca.2011.05.007
|